These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18997469)

  • 1. Chronic kidney disease in Japan from early predictions to current facts.
    Iseki K
    Nephron Clin Pract; 2008; 110(4):c268-72. PubMed ID: 18997469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal outcomes in chronic kidney disease.
    Iseki K
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():27-30. PubMed ID: 20586944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology of CKD in Japan].
    Iseki K
    Nihon Rinsho; 2008 Sep; 66(9):1650-6. PubMed ID: 18788390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
    Imai E; Matsuo S; Makino H; Watanabe T; Akizawa T; Nitta K; Iimuro S; Ohashi Y; Hishida A;
    Hypertens Res; 2008 Jun; 31(6):1101-7. PubMed ID: 18716357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia.
    Chen N; Hsu CC; Yamagata K; Langham R
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():31-6. PubMed ID: 20586945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the development of end-stage renal disease.
    Iseki K
    Clin Exp Nephrol; 2005 Mar; 9(1):5-14. PubMed ID: 15830267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration.
    Dirks JH; de Zeeuw D; Agarwal SK; Atkins RC; Correa-Rotter R; D'Amico G; Bennett PH; El Nahas M; Valdes RH; Kaseje D; Katz IJ; Naicker S; Rodriguez-Iturbe B; Schieppati A; Shaheen F; Sitthi-Amorn C; Solez K; Viberti G; Remuzzi G; Weening JJ;
    Kidney Int Suppl; 2005 Sep; (98):S1-6. PubMed ID: 16108963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing gender difference in the incidence of chronic dialysis therapy in Japan.
    Iseki K; Nakai S; Shinzato T; Nagura Y; Akiba T;
    Ther Apher Dial; 2005 Oct; 9(5):407-11. PubMed ID: 16202016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities.
    McClellan WM; Satko SG; Gladstone E; Krisher JO; Narva AS; Freedman BI
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S100-6. PubMed ID: 19231753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
    Iseki K
    J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different regional dynamics of end-stage renal disease in Japan by different causes.
    Kato N; Usami T; Fukuda M; Motokawa M; Kamiya Y; Yoshida A; Kimura G
    Nephrology (Carlton); 2005 Aug; 10(4):400-4. PubMed ID: 16109089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan.
    Hwang SJ; Tsai JC; Chen HC
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():3-9. PubMed ID: 20586940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for proteinuria and chronic kidney disease risk factors in Kinshasa: a World Kidney Day 2007 study.
    Sumaili EK; Nseka NM; Lepira FB; Krzesinski JM; Makulo JR; Bukabau JB; Nkoy JB; Mokoli VM; Longokolo MM; Owandjalola JA; Kayembe PK
    Nephron Clin Pract; 2008; 110(4):c220-8. PubMed ID: 18974653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inadequate treatment of cardiovascular disease and cardiovascular disease risk factors in dialysis patients: a commentary.
    Culleton BF; Hemmelgarn B
    Semin Dial; 2004; 17(5):342-5. PubMed ID: 15461738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA
    Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projecting the number of patients with end-stage renal disease in the United States to the year 2015.
    Gilbertson DT; Liu J; Xue JL; Louis TA; Solid CA; Ebben JP; Collins AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3736-41. PubMed ID: 16267160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology and risk factors of chronic renal diseases: a regional level of the problem].
    Smirnov AV; Dobronravov VA; Bodur-Oorzhak ASh; Zver'kov RV; Larionova VI; Glazkov PB; Bogdanova MA; Mnuskina MM; Kaiukov IG; Sanchi MN
    Ter Arkh; 2005; 77(6):20-7. PubMed ID: 16078595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of chronic kidney disease: time for a course correction.
    Bauer C; Melamed ML; Hostetter TH
    J Am Soc Nephrol; 2008 May; 19(5):844-6. PubMed ID: 18385419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.